1. Home
  2. TATT vs CTMX Comparison

TATT vs CTMX Comparison

Compare TATT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TATT
  • CTMX
  • Stock Information
  • Founded
  • TATT 1985
  • CTMX 2008
  • Country
  • TATT Israel
  • CTMX United States
  • Employees
  • TATT N/A
  • CTMX N/A
  • Industry
  • TATT Aerospace
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TATT Industrials
  • CTMX Health Care
  • Exchange
  • TATT Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • TATT 379.0M
  • CTMX 444.3M
  • IPO Year
  • TATT 1987
  • CTMX 2015
  • Fundamental
  • Price
  • TATT $25.86
  • CTMX $2.33
  • Analyst Decision
  • TATT Strong Buy
  • CTMX Strong Buy
  • Analyst Count
  • TATT 3
  • CTMX 2
  • Target Price
  • TATT $36.00
  • CTMX $5.00
  • AVG Volume (30 Days)
  • TATT 329.0K
  • CTMX 3.3M
  • Earning Date
  • TATT 05-19-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • TATT N/A
  • CTMX N/A
  • EPS Growth
  • TATT 81.73
  • CTMX 128.27
  • EPS
  • TATT 1.14
  • CTMX 0.49
  • Revenue
  • TATT $160,170,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • TATT $18.62
  • CTMX N/A
  • Revenue Next Year
  • TATT $10.62
  • CTMX N/A
  • P/E Ratio
  • TATT $22.37
  • CTMX $4.78
  • Revenue Growth
  • TATT 30.57
  • CTMX 23.81
  • 52 Week Low
  • TATT $12.61
  • CTMX $0.40
  • 52 Week High
  • TATT $36.49
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • TATT 39.35
  • CTMX 49.57
  • Support Level
  • TATT $25.52
  • CTMX $2.08
  • Resistance Level
  • TATT $27.06
  • CTMX $3.10
  • Average True Range (ATR)
  • TATT 0.93
  • CTMX 0.26
  • MACD
  • TATT -0.08
  • CTMX -0.11
  • Stochastic Oscillator
  • TATT 19.77
  • CTMX 15.20

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: